Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03225313Completed
Randomised, double-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Theodor Bilharz Research Institute. Primary endpoints: Immediate Postoperative Pain, Postoperative Pain at 2 Hours After Procedure and 1 more. Started Aug 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03225313.